306 related articles for article (PubMed ID: 35456044)
21. The eye in epidermolysis bullosa.
Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D
Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041
[TBL] [Abstract][Full Text] [Related]
22. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
Kim M; Murrell DF
Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
[TBL] [Abstract][Full Text] [Related]
23. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
South AP; O'Toole EA
Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
[TBL] [Abstract][Full Text] [Related]
24. Epidermolysis bullosa in animals: a review.
Medeiros GX; Riet-Correa F
Vet Dermatol; 2015 Feb; 26(1):3-13, e1-2. PubMed ID: 25354580
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis and molecular genetics of epidermolysis bullosa.
Pulkkinen L; Uitto J
Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment and management of cutaneous squamous cell carcinoma in patients with dystrophic epidermolysis bullosa - a case report.
Rotschein P; Vokurková J; Bučková H
Acta Chir Plast; 2021; 63(4):196-200. PubMed ID: 35042364
[TBL] [Abstract][Full Text] [Related]
27. Dominant dystrophic epidermolysis bullosa with congenital absence of skin and brachydactyly of the great toes.
Sawka E; Funk T
Pediatr Dermatol; 2021 Sep; 38(5):1251-1254. PubMed ID: 34338359
[TBL] [Abstract][Full Text] [Related]
28. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
[TBL] [Abstract][Full Text] [Related]
29. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
Knaup J; Gruber C; Krammer B; Ziegler V; Bauer J; Verwanger T
Anal Cell Pathol (Amst); 2011; 34(6):339-53. PubMed ID: 22002724
[TBL] [Abstract][Full Text] [Related]
30. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
Rodeck U; Uitto J
J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
[TBL] [Abstract][Full Text] [Related]
31. Epidermolysis Bullosa: Pediatric Perspectives.
Hon KL; Chu S; Leung AKC
Curr Pediatr Rev; 2022; 18(3):182-190. PubMed ID: 34036913
[TBL] [Abstract][Full Text] [Related]
32. Genetic abnormalities and clinical classification of epidermolysis bullosa.
Mitsuhashi Y; Hashimoto I
Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S29-33. PubMed ID: 12677430
[TBL] [Abstract][Full Text] [Related]
33. Gross motor development in children with epidermolysis bullosa.
Gorrie A; Saad R; Garside L; Bailie C; Wargon O
Child Care Health Dev; 2024 Jan; 50(1):e13194. PubMed ID: 38108617
[TBL] [Abstract][Full Text] [Related]
34. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
35. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.
Yuen WY; Jonkman MF
J Am Acad Dermatol; 2011 Oct; 65(4):780-789. PubMed ID: 21624701
[TBL] [Abstract][Full Text] [Related]
36. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.
Krämer S; Lucas J; Gamboa F; Peñarrocha Diago M; Peñarrocha Oltra D; Guzmán-Letelier M; Paul S; Molina G; Sepúlveda L; Araya I; Soto R; Arriagada C; Lucky AW; Mellerio JE; Cornwall R; Alsayer F; Schilke R; Antal MA; Castrillón F; Paredes C; Serrano MC; Clark V
Spec Care Dentist; 2020 Nov; 40 Suppl 1(Suppl 1):3-81. PubMed ID: 33202040
[TBL] [Abstract][Full Text] [Related]
37. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Welponer T; Weber DD; Trattner L; Tockner B; Aminzadeh-Gohari S; Leb-Reichl V; Kaufmann A; Zauner R; Wimmer M; Wally V; Felder TK; Strunk D; Koller U; Bauer JW; Kofler B; Guttmann-Gruber C; Piñon Hofbauer J
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):112-123. PubMed ID: 37669776
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
[TBL] [Abstract][Full Text] [Related]
40. Age and etiology of childhood epidermolysis bullosa mortality.
Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
